25 XP   0   0   10

Fluoropharma Medical
Buy, Hold or Sell?

Let's analyse Fluoropharma together

PenkeI guess you are interested in Fluoropharma Medical. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Fluoropharma Medical. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Fluoropharma Medical

I send you an email if I find something interesting about Fluoropharma Medical.

Quick analysis of Fluoropharma (30 sec.)










What can you expect buying and holding a share of Fluoropharma? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.30
Expected worth in 1 year
$-0.57
How sure are you?
12.5%

+ What do you gain per year?

Total Gains per Share
$-0.27
Return On Investment
-270,724.3%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0001
How sure are you?
50%

1. Valuation of Fluoropharma (5 min.)




Live pricePrice per Share (EOD)

$0.00

Intrinsic Value Per Share

$-0.26 - $0.47

Total Value Per Share

$-0.55 - $0.17

2. Growth of Fluoropharma (5 min.)




Is Fluoropharma growing?

Current yearPrevious yearGrowGrow %
How rich?-$10.1m-$7.8m-$2.3m-22.8%

How much money is Fluoropharma making?

Current yearPrevious yearGrowGrow %
Making money-$2m-$3.1m$1.1m54.3%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Fluoropharma (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of Fluoropharma? (5 min.)

Welcome investor! Fluoropharma's management wants to use your money to grow the business. In return you get a share of Fluoropharma.

What can you expect buying and holding a share of Fluoropharma?

First you should know what it really means to hold a share of Fluoropharma. And how you can make/lose money.

Speculation

The Price per Share of Fluoropharma is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Fluoropharma.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Fluoropharma, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.30. Based on the TTM, the Book Value Change Per Share is $-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Fluoropharma.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.08-75,104.9%-0.08-75,104.9%-0.11-109,090.5%-0.13-130,194.7%-0.08-81,698.0%
Usd Book Value Change Per Share-0.07-67,681.1%-0.07-67,681.1%-0.09-89,420.4%-0.08-77,900.7%-0.04-37,137.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.07-67,681.1%-0.07-67,681.1%-0.09-89,420.4%-0.08-77,900.7%-0.04-37,137.4%
Usd Price Per Share0.11-0.11-0.30-0.45-0.37-
Price to Earnings Ratio-1.48--1.48--2.75--3.41--2.13-
Price-to-Total Gains Ratio-1.65--1.65--3.35--6.64--4.28-
Price to Book Ratio-0.38--0.38--1.31--1.03-0.30-
Price-to-Total Gains Ratio-1.65--1.65--3.35--6.64--4.28-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.07-0.08
Usd Total Gains Per Share-0.07-0.08
Gains per Quarter (10000000 shares)-676,810.66-779,006.84
Gains per Year (10000000 shares)-2,707,242.65-3,116,027.35
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-2707243-27072530-3116027-3116037
20-5414485-54144960-6232055-6232064
30-8121728-81217390-9348082-9348091
40-10828971-108289820-12464109-12464118
50-13536213-135362250-15580137-15580145
60-16243456-162434680-18696164-18696172
70-18950699-189507110-21812191-21812199
80-21657941-216579540-24928219-24928226
90-24365184-243651970-28044246-28044253
100-27072427-270724400-31160274-31160280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.07.01.00.0%0.07.01.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.07.00.012.5%1.07.00.012.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.07.00.012.5%1.07.00.012.5%

Fundamentals of Fluoropharma

About Fluoropharma Medical

FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. Its product candidates include BFPET, an imaging agent that has completed a Phase I clinical trial in stress-testing for patients with presumptive or proven coronary artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase IIa clinical trial to assess myocardial blood flow and metabolism in patients with CAD. The company has license agreements with Massachusetts General Hospital and Sinotau USA; and clinical research agreements with Pharmaceutical Product Development, LLC, as well as Cardiovascular Imaging Technologies. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey.

Fundamental data was last updated by Penke on 2024-05-16 14:42:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Fluoropharma Medical.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Fluoropharma earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Fluoropharma to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Fluoropharma Medical:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-9.5%+9.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--176.9%+176.9%
TTM--211.5%+211.5%
YOY--266.0%+266.0%
5Y--401.1%+401.1%
10Y-9.5%-552.5%+543.0%
1.1.2. Return on Assets

Shows how efficient Fluoropharma is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Fluoropharma to the Biotechnology industry mean.
  • -612.3% Return on Assets means that Fluoropharma generated $-6.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Fluoropharma Medical:

  • The MRQ is -612.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -612.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-612.3%TTM-612.3%0.0%
TTM-612.3%YOY-324.5%-287.8%
TTM-612.3%5Y-237.4%-375.0%
5Y-237.4%10Y-208.9%-28.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-612.3%-12.1%-600.2%
TTM-612.3%-11.7%-600.6%
YOY-324.5%-11.0%-313.5%
5Y-237.4%-13.2%-224.2%
10Y-208.9%-14.5%-194.4%
1.1.3. Return on Equity

Shows how efficient Fluoropharma is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Fluoropharma to the Biotechnology industry mean.
  • 0.0% Return on Equity means Fluoropharma generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Fluoropharma Medical:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-58.3%+58.3%
5Y-58.3%10Y-36.4%-21.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--15.4%+15.4%
TTM--15.0%+15.0%
YOY--13.7%+13.7%
5Y-58.3%-17.8%-40.5%
10Y-36.4%-19.3%-17.1%

1.2. Operating Efficiency of Fluoropharma Medical.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Fluoropharma is operating .

  • Measures how much profit Fluoropharma makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Fluoropharma to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Fluoropharma Medical:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-9.0%+9.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--339.4%+339.4%
TTM--221.5%+221.5%
YOY--281.8%+281.8%
5Y--408.0%+408.0%
10Y-9.0%-528.5%+519.5%
1.2.2. Operating Ratio

Measures how efficient Fluoropharma is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Fluoropharma Medical:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.660-0.660
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.076-3.076
TTM-3.246-3.246
YOY-3.609-3.609
5Y-5.190-5.190
10Y0.6606.896-6.236

1.3. Liquidity of Fluoropharma Medical.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Fluoropharma is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.00 means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Fluoropharma Medical:

  • The MRQ is 0.005. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.005. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.005TTM0.0050.000
TTM0.005YOY0.073-0.068
TTM0.0055Y1.328-1.323
5Y1.32810Y2.016-0.688
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0053.802-3.797
TTM0.0054.158-4.153
YOY0.0735.249-5.176
5Y1.3286.087-4.759
10Y2.0166.428-4.412
1.3.2. Quick Ratio

Measures if Fluoropharma is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Fluoropharma to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Fluoropharma Medical:

  • The MRQ is 0.002. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.002. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.002TTM0.0020.000
TTM0.002YOY0.033-0.031
TTM0.0025Y1.289-1.286
5Y1.28910Y1.924-0.635
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0023.246-3.244
TTM0.0023.811-3.809
YOY0.0335.150-5.117
5Y1.2895.929-4.640
10Y1.9246.351-4.427

1.4. Solvency of Fluoropharma Medical.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Fluoropharma assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Fluoropharma to Biotechnology industry mean.
  • A Debt to Asset Ratio of 31.41 means that Fluoropharma assets are financed with 3,140.8% credit (debt) and the remaining percentage (100% - 3,140.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Fluoropharma Medical:

  • The MRQ is 31.408. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 31.408. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ31.408TTM31.4080.000
TTM31.408YOY9.063+22.345
TTM31.4085Y9.803+21.604
5Y9.80310Y6.902+2.901
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ31.4080.351+31.057
TTM31.4080.343+31.065
YOY9.0630.278+8.785
5Y9.8030.366+9.437
10Y6.9020.379+6.523
1.4.2. Debt to Equity Ratio

Measures if Fluoropharma is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Fluoropharma to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Fluoropharma Medical:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.034-0.034
5Y0.03410Y0.036-0.002
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.402-0.402
TTM-0.415-0.415
YOY-0.351-0.351
5Y0.0340.442-0.408
10Y0.0360.469-0.433

2. Market Valuation of Fluoropharma Medical

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Fluoropharma generates.

  • Above 15 is considered overpriced but always compare Fluoropharma to the Biotechnology industry mean.
  • A PE ratio of -1.48 means the investor is paying $-1.48 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Fluoropharma Medical:

  • The EOD is -0.001. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.485. Based on the earnings, the company is expensive. -2
  • The TTM is -1.485. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.001MRQ-1.485+1.483
MRQ-1.485TTM-1.4850.000
TTM-1.485YOY-2.750+1.265
TTM-1.4855Y-3.415+1.930
5Y-3.41510Y-2.134-1.281
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.001-2.413+2.412
MRQ-1.485-2.573+1.088
TTM-1.485-2.766+1.281
YOY-2.750-3.948+1.198
5Y-3.415-6.374+2.959
10Y-2.134-6.660+4.526
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Fluoropharma Medical:

  • The EOD is -0.004. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.334. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.334. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.004MRQ-4.334+4.330
MRQ-4.334TTM-4.3340.000
TTM-4.334YOY-3.830-0.504
TTM-4.3345Y-5.363+1.029
5Y-5.36310Y-4.568-0.795
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.004-3.085+3.081
MRQ-4.334-3.312-1.022
TTM-4.334-3.529-0.805
YOY-3.830-5.200+1.370
5Y-5.363-8.251+2.888
10Y-4.568-8.842+4.274
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Fluoropharma is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.38 means the investor is paying $-0.38 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Fluoropharma Medical:

  • The EOD is 0.000. Based on the equity, the company is expensive. -2
  • The MRQ is -0.375. Based on the equity, the company is expensive. -2
  • The TTM is -0.375. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-0.375+0.375
MRQ-0.375TTM-0.3750.000
TTM-0.375YOY-1.308+0.932
TTM-0.3755Y-1.031+0.656
5Y-1.03110Y0.303-1.333
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.0002.082-2.082
MRQ-0.3752.031-2.406
TTM-0.3752.076-2.451
YOY-1.3082.688-3.996
5Y-1.0313.692-4.723
10Y0.3034.104-3.801
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Fluoropharma Medical compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.068-0.0680%-0.089+32%-0.078+15%-0.037-45%
Book Value Per Share---0.297-0.2970%-0.229-23%-0.131-56%-0.071-76%
Current Ratio--0.0050.0050%0.073-94%1.328-100%2.016-100%
Debt To Asset Ratio--31.40831.4080%9.063+247%9.803+220%6.902+355%
Debt To Equity Ratio----0%-0%0.034-100%0.036-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.075-0.0750%-0.109+45%-0.130+73%-0.082+9%
Free Cash Flow Per Share---0.026-0.0260%-0.078+204%-0.081+215%-0.060+133%
Free Cash Flow To Equity Per Share---0.008-0.0080%0.000-9841%-0.033+325%-0.009+13%
Gross Profit Margin--1.8031.8030%1.764+2%1.313+37%1.349+34%
Intrinsic Value_10Y_max--0.470--------
Intrinsic Value_10Y_min---0.255--------
Intrinsic Value_1Y_max---0.045--------
Intrinsic Value_1Y_min---0.068--------
Intrinsic Value_3Y_max---0.065--------
Intrinsic Value_3Y_min---0.168--------
Intrinsic Value_5Y_max---0.001--------
Intrinsic Value_5Y_min---0.229--------
Market Cap3426.230-111400%3820246.4503820246.4500%10278690.000-63%15496153.044-75%12683046.903-70%
Net Profit Margin----0%-0%-0%-0.0950%
Operating Margin----0%-0%-0%-0.0900%
Operating Ratio----0%-0%-0%0.660-100%
Pb Ratio0.000+100%-0.375-0.3750%-1.308+248%-1.031+175%0.303-224%
Pe Ratio-0.001+100%-1.485-1.4850%-2.750+85%-3.415+130%-2.134+44%
Price Per Share0.000-111400%0.1120.1120%0.300-63%0.452-75%0.370-70%
Price To Free Cash Flow Ratio-0.004+100%-4.334-4.3340%-3.830-12%-5.363+24%-4.568+5%
Price To Total Gains Ratio-0.001+100%-1.647-1.6470%-3.355+104%-6.639+303%-4.281+160%
Quick Ratio--0.0020.0020%0.033-93%1.289-100%1.924-100%
Return On Assets---6.123-6.1230%-3.245-47%-2.374-61%-2.089-66%
Return On Equity----0%-0%-0.5830%-0.3640%
Total Gains Per Share---0.068-0.0680%-0.089+32%-0.078+15%-0.037-45%
Usd Book Value---10179292.000-10179292.0000%-7860383.000-23%-4502944.400-56%-2423808.250-76%
Usd Book Value Change Per Share---0.068-0.0680%-0.089+32%-0.078+15%-0.037-45%
Usd Book Value Per Share---0.297-0.2970%-0.229-23%-0.131-56%-0.071-76%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.075-0.0750%-0.109+45%-0.130+73%-0.082+9%
Usd Free Cash Flow---881414.000-881414.0000%-2683583.000+204%-2780351.600+215%-2055578.250+133%
Usd Free Cash Flow Per Share---0.026-0.0260%-0.078+204%-0.081+215%-0.060+133%
Usd Free Cash Flow To Equity Per Share---0.008-0.0080%0.000-9841%-0.033+325%-0.009+13%
Usd Market Cap3426.230-111400%3820246.4503820246.4500%10278690.000-63%15496153.044-75%12683046.903-70%
Usd Price Per Share0.000-111400%0.1120.1120%0.300-63%0.452-75%0.370-70%
Usd Profit---2049861.000-2049861.0000%-3163657.000+54%-1848448.028-10%-1166461.393-43%
Usd Revenue----0%-0%-0%34604.375-100%
Usd Total Gains Per Share---0.068-0.0680%-0.089+32%-0.078+15%-0.037-45%
 EOD+2 -6MRQTTM+0 -0YOY+14 -145Y+15 -1410Y+13 -18

3.2. Fundamental Score

Let's check the fundamental score of Fluoropharma Medical based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.001
Price to Book Ratio (EOD)Between0-10.000
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.002
Current Ratio (MRQ)Greater than10.005
Debt to Asset Ratio (MRQ)Less than131.408
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-6.123
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Fluoropharma Medical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.310
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2016-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets335
Total Liabilities10,514
Total Stockholder Equity-10,179
 As reported
Total Liabilities 10,514
Total Stockholder Equity+ -10,179
Total Assets = 335

Assets

Total Assets335
Total Current Assets48
Long-term Assets287
Total Current Assets
Cash And Cash Equivalents 25
Other Current Assets 3
Total Current Assets  (as reported)48
Total Current Assets  (calculated)28
+/- 20
Long-term Assets
Property Plant Equipment 7
Intangible Assets 280
Long-term Assets  (as reported)287
Long-term Assets  (calculated)287
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities10,514
Long-term Liabilities0
Total Stockholder Equity-10,179
Total Current Liabilities
Short-term Debt 5,825
Short Long Term Debt 5,825
Accounts payable 1,414
Other Current Liabilities 2,867
Total Current Liabilities  (as reported)10,514
Total Current Liabilities  (calculated)15,930
+/- 5,416
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock34
Retained Earnings -35,178
Other Stockholders Equity 24,959
Total Stockholder Equity (as reported)-10,179
Total Stockholder Equity (calculated)-10,185
+/- 5
Other
Cash and Short Term Investments 25
Common Stock Shares Outstanding 33,556
Current Deferred Revenue408
Liabilities and Stockholders Equity 335
Net Debt 5,800
Net Tangible Assets -10,464
Net Working Capital -10,466
Preferred Stock Total Equity 5
Short Long Term Debt Total 5,825



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
> Total Assets 
26
8
2
1
3,546
1,614
1,916
820
975
335
3359758201,9161,6143,54612826
   > Total Current Assets 
22
5
0
0
3,315
1,381
1,831
451
645
48
486454511,8311,3813,31500522
       Cash And Cash Equivalents 
7
0
0
0
3,265
1,304
1,143
252
291
25
252912521,1431,3043,2650007
       Short-term Investments 
0
0
0
0
0
0
635
40
0
0
0040635000000
       Net Receivables 
5
0
0
0
0
0
0
0
0
0
0000000005
       Inventory 
10
4
0
0
0
0
0
0
0
0
00000000410
   > Long-term Assets 
5
3
2
1
231
232
85
369
330
287
287330369852322311235
       Property Plant Equipment 
5
3
2
1
170
177
35
12
11
7
71112351771701235
       Intangible Assets 
0
0
0
0
61
55
49
358
319
280
2803193584955610000
> Total Liabilities 
39
37
47
59
380
236
2,972
5,617
8,835
10,514
10,5148,8355,6172,97223638059473739
   > Total Current Liabilities 
33
37
47
59
380
236
2,972
5,617
8,835
10,514
10,5148,8355,6172,97223638059473733
       Short-term Debt 
25
27
39
48
0
0
0
2,123
4,486
5,825
5,8254,4862,12300048392725
       Short Long Term Debt 
0
0
0
0
0
0
0
2,123
4,349
5,825
5,8254,3492,1230000000
       Accounts payable 
5
2
0
0
341
138
183
1,064
1,220
1,414
1,4141,2201,0641831383410025
       Other Current Liabilities 
4
8
8
10
39
98
2,789
1,506
1,583
2,867
2,8671,5831,5062,789983910884
   > Long-term Liabilities 
6
0
0
0
0
0
0
0
0
0
0000000006
> Total Stockholder Equity
-13
-29
-44
-57
3,166
1,378
-1,056
-4,797
-7,860
-10,179
-10,179-7,860-4,797-1,0561,3783,166-57-44-29-13
   Common Stock
11
11
11
11
22
24
26
29
33
34
34332926242211111111
   Retained Earnings -35,178-32,604-28,867-24,175-16,891-12,874-120-107-89-73
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 
49
49
52
52
16,015
18,242
23,084
24,034
24,706
24,959
24,95924,70624,03423,08418,24216,01552524949



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2016-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-44
Gross Profit-44-44
 
Operating Income (+$)
Gross Profit-44
Operating Expense-2,159
Operating Income-2,202-2,202
 
Operating Expense (+$)
Research Development511
Selling General Administrative2
Selling And Marketing Expenses1,645
Operating Expense2,1592,159
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-1,262
Net Interest Income-1,262
 
Pretax Income (+$)
Operating Income-2,202
Net Interest Income-1,262
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,050-2,355
EBIT - interestExpense = -2,202
-2,050
-2,050
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-2,202-2,050
Earnings Before Interest and Taxes (EBITDA)-2,159
 
After tax Income (+$)
Income Before Tax-2,050
Tax Provision-0
Net Income From Continuing Ops-2,050-2,050
Net Income-2,050
Net Income Applicable To Common Shares-2,573
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,202
Total Other Income/Expenses Net1531,262
 

Technical Analysis of Fluoropharma
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Fluoropharma. The general trend of Fluoropharma is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Fluoropharma's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Fluoropharma Medical.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Tweet this
Fluoropharma Medical Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Fluoropharma Medical. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Fluoropharma Medical Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Fluoropharma Medical. The current macd is 0.0000.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Fluoropharma price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Fluoropharma. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Fluoropharma price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Fluoropharma Medical Daily Moving Average Convergence/Divergence (MACD) ChartFluoropharma Medical Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Fluoropharma Medical. The current adx is 30.30.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Fluoropharma shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Fluoropharma Medical Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Fluoropharma Medical. The current sar is 0.00013226.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Fluoropharma Medical Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Fluoropharma Medical. The current rsi is 35.31. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Fluoropharma Medical Daily Relative Strength Index (RSI) ChartFluoropharma Medical Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Fluoropharma Medical. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Fluoropharma price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Fluoropharma Medical Daily Stochastic Oscillator ChartFluoropharma Medical Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Fluoropharma Medical. The current cci is -66.66666667.

Fluoropharma Medical Daily Commodity Channel Index (CCI) ChartFluoropharma Medical Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Fluoropharma Medical. The current cmo is -43.95005553.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Fluoropharma Medical Daily Chande Momentum Oscillator (CMO) ChartFluoropharma Medical Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Fluoropharma Medical. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Fluoropharma Medical Daily Williams %R ChartFluoropharma Medical Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Fluoropharma Medical.

Fluoropharma Medical Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Fluoropharma Medical. The current atr is 0.0000.

Fluoropharma Medical Daily Average True Range (ATR) ChartFluoropharma Medical Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Fluoropharma Medical. The current obv is -1,564,993.

Fluoropharma Medical Daily On-Balance Volume (OBV) ChartFluoropharma Medical Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Fluoropharma Medical. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Fluoropharma Medical Daily Money Flow Index (MFI) ChartFluoropharma Medical Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Fluoropharma Medical.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

Fluoropharma Medical Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Fluoropharma Medical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.310
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Fluoropharma with someone you think should read this too:
  • Are you bullish or bearish on Fluoropharma? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Fluoropharma? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Fluoropharma Medical

I send you an email if I find something interesting about Fluoropharma Medical.


Comments

How you think about this?

Leave a comment

Stay informed about Fluoropharma Medical.

Receive notifications about Fluoropharma Medical in your mailbox!